enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Laron syndrome - Wikipedia

    en.wikipedia.org/wiki/Laron_syndrome

    Laron syndrome (LS), also known as growth hormone insensitivity or growth hormone receptor deficiency (GHRD), is an autosomal recessive disorder characterized by a lack of insulin-like growth factor 1 (IGF-1; somatomedin-C) production in response to growth hormone (GH; hGH; somatotropin). [6]

  3. Growth hormone deficiency - Wikipedia

    en.wikipedia.org/wiki/Growth_hormone_deficiency

    Treatment is by growth hormone replacement using synthetic human growth hormone. [1] The frequency of the condition is unclear. [2] Most cases are initially noticed in children. [1] The genetic forms of this disease are estimated to affect about 1 in 7,000 people. [3] Most types occur equally in males and females though males are more often ...

  4. Mecasermin - Wikipedia

    en.wikipedia.org/wiki/Mecasermin

    Mecasermin, sold under the brand name Increlex, also known as recombinant human insulin-like growth factor-1 (rhIGF-1), is a recombinant form of human insulin-like growth factor 1 (IGF-I) which is used in the long-term treatment of growth failure and short stature in children with severe primary IGF-I deficiency, for instance due to growth hormone deficiency or Laron syndrome (growth hormone ...

  5. Insulin-like growth factor 1 - Wikipedia

    en.wikipedia.org/wiki/Insulin-like_growth_factor_1

    Low IGF-1 levels are shown to increase the risk of developing type 2 diabetes and insulin resistance. [67] On the other hand, a high IGF-1 bioavailability in people with diabetes may delay or prevent diabetes-associated complications, as it improves impaired small blood vessel function. [67] IGF-1 has been characterized as an insulin sensitizer ...

  6. Growth hormone therapy - Wikipedia

    en.wikipedia.org/wiki/Growth_hormone_therapy

    GH is one of the treatment options an experienced endocrinologist may use when treating a child with PWS. [17] GH can help children with PWS in height, weight, body mass, strength, and agility. [citation needed]. Reports have indicated increase of growth rate (especially in the first year of treatment) and a variety of other positive effects ...

  7. Tercica - Wikipedia

    en.wikipedia.org/wiki/Tercica

    Tercica applied to the Food and Drug Administration (FDA) for approval of Increlex as a long-term therapy for growth failure in children with severe primary IGF-1 deficiency (Primary IGFD), which is characterized by growth failure, and as a treatment for children with growth hormone (GH) gene deletion who have developed neutralizing antibodies ...

  8. Bone growth factor - Wikipedia

    en.wikipedia.org/wiki/Bone_growth_factor

    A bone growth factor is a growth factor that stimulates the growth of bone tissue. [1] [2]Known bone growth factors include insulin-like growth factor-1 (IGF-1), insulin-like growth factor-2 (IGF-2), transforming growth factor beta (TGF-β), fibroblast growth factors (FGFs), platelet-derived growth factor (PDGF), parathyroid hormone-related peptide (PTHrP), bone morphogenetic proteins (BMPs ...

  9. Insulin-like growth factor - Wikipedia

    en.wikipedia.org/wiki/Insulin-like_growth_factor

    The IGF-1 receptor is the "physiological" receptor. IGF-1 binds to it at significantly higher affinity than it binds the insulin receptor. Like the insulin receptor, the IGF-1 receptor is a receptor tyrosine kinase—meaning the receptor signals by causing the addition of a phosphate molecule on particular tyrosines. The IGF-2 receptor only ...

  1. Related searches low igf 1 in children treatment center reviews and prices california chart

    igf 1 levelsigf1r
    igf 1 growth rateigf 1 protein
    what does igf 1 do